THTX: Theratechnologies Inc. Company Short-Term Debt
Current price action for Theratechnologies Inc. (THTX) on the GURU.Markets platform demonstrates a value of 0.00, driven by a transition toward profitable sales growth of specialized HIV treatments and a reduction in oncology R&D expenditures. The business relies on outsourcing production cycles and testing to third-party contractors, while utilizing external marketing for the global promotion of its therapeutic solutions.
Metric breakdowns and analytics for Theratechnologies, Inc (THTX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Theratechnologies Inc.|THTX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Theratechnologies Inc.|THTX - Company Total Debt|Debt to Book Capitalization Ratio Theratechnologies Inc.|THTX - Company Long-Term Liabilities|Company Current Liabilities Theratechnologies|Quick Liquidity theratech.com
- net income and valuation multiples indicators:
Initial company analysis:THTX - Theratechnologies
This metric measures the total volume of liabilities with a maturity of up to one year. By analyzing the short-term debt profile, an investor assesses liquidity and the absence of settlement distortions. The metric is sensitive to payment regularity, where a steady reduction of risks protects capital. For Theratechnologies Inc. (THTX), a low debt load confirms business resilience, enabling the company to effectively monetize stable demand for vital endocrine drugs.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Nektar Therapeutics Inc (NKTR) - Short-Term Debt|UPB: Company Current Liabilities|Zenas Corp - Amount of Current Liabilities|IMNM: Company Short-Term Debts|gossamerbio.com - Company Short-Term Loans and Borrowings|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Short-Term Debt Septerna, Inc. SEPN|Company Short-Term Debt Pieris Pharmaceuticals Inc (PVLA)|SVRA (Savara Pharma) - Company Short-Term Loans and Borrowings|Company Short-Term Debts RIGL (Rigel Pharmaceuticals)|Company Short-Term Debts anaptysbio.com ANAB|ATXS: Company Current Liabilities|enGene Holdings Inc - Amount of Current Liabilities|RAPT: Company Short-Term Debts|Short-Term Debt Aerovate Therapeutics (JBIO)|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|Company Current Liabilities kyvernatx.com (KYTX)|Company Short-Term Debts TLSA|CABA (Cabaletta Bio Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Ventyx Bio VTYX|AVTX: Company Short-Term Indebtedness|ELDN - Company Short-Term Debt|Short-Term Debt agenusbio.com|Climb Bio (CLYM) - Company Short-Term Debt|ZURA (zurabio.com) - Company Short-Term Debt|Company Short-Term Debt aTyr|Short-Term Debt Adagene Corp ADAG|Company Short-Term Debts IMA|shattucklabs.com (STTK) - Short-Term Indebtedness|Company Short-Term Debts EQ (Equillium)|Short-Term Debt Volume Connect Biopharma Holdings (CNTB)|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|inflarx.de (IFRX) - Company Short-Term Debt|XFOR - Short-Term Debt Volume|Company Current Liabilities ACET|CELU: Company Short-Term Loans and Borrowings|Company Short-Term Debts INMB|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debt Kezar Life Sciences KZR|SABS: Company Short-Term Indebtedness|Akari Therapeutics Plc - Company Short-Term Debts|Enlivex Therapeutics (ENLV) - Company Current Liabilities|QTTB (q32bio.com) - Company Current Liabilities|GOVX - Short-Term Debt Volume|Company Current Liabilities EDSA|IBIO (ibioinc.com) - Amount of Current Liabilities|Company Short-Term Debts CARM|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Bolt Biotherapeutics, Inc. - Company Current Liabilities|Amount of Current Liabilities HCWB (HCW Biologics, Inc.)|APVO: Company Current Liabilities|AIM (aimimmuno.com) - Company Short-Term Indebtedness|aditxt.com (ADTX) - Company Short-Term Debt|Current Liabilities GRI (GRI Bio Inc)|XRTX (XORTX) - Company Short-Term Debts|HIND: Company Short-Term Loans and Borrowings|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Company Short-Term Debt Scinai Immunotherapeutics Ltd. SCNI|Company Short-Term Loans and Borrowings CALI|AFMD - Company Short-Term Debt|Allakos Inc. (ALLK) - Company Current Liabilities|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Current Liabilities ITOS|OCEA: Company Short-Term Loans and Borrowings|Company Short-Term Debts TCBP|Short-Term Debt Volume Third Harmonic Bio Inc